โ† All PMH-C Flashcard Decks

Psychopharmacology Flashcards

7 cards from real PMH-C practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 7 Psychopharmacology flashcards as text
  1. A perinatal patient with ADHD asks about stimulant medication safety during breastfeeding. What is the most accurate statement?

    Answer: Data are limited; amphetamines concentrate in breast milk and infant exposure warrants careful consideration

    Amphetamine-based stimulants concentrate in breast milk with milk-to-plasma ratios >1, so use during breastfeeding requires individualized risk-benefit discussion.

  2. Which physiological change in pregnancy most significantly affects the volume of distribution of psychotropic medications?

    Answer: Expanded plasma volume and increased body fat

    Pregnancy-related plasma volume expansion (~50%) and increased body fat increase the volume of distribution of lipophilic psychotropics, often lowering effective serum levels.

  3. A patient is prescribed an SNRI for perinatal depression. Which additional counseling point differentiates SNRIs from SSRIs in the perinatal context?

    Answer: SNRIs have norepinephrine effects that may contribute to hypertension and should be monitored in preeclamptic patients

    SNRIs' noradrenergic activity can elevate blood pressure, which is especially relevant in patients at risk for or diagnosed with preeclampsia.

  4. A patient stabilized on aripiprazole for bipolar disorder plans to breastfeed. What is the most clinically relevant concern with this medication during lactation?

    Answer: Aripiprazole has been shown to suppress prolactin and may inhibit milk production

    Aripiprazole's partial dopamine agonism can suppress prolactin, potentially reducing milk supply in breastfeeding mothers.

  5. What is the primary rationale for preferring lamotrigine over valproate in a woman of reproductive age with bipolar II disorder?

    Answer: Valproate carries a significantly higher teratogenic risk and is associated with fetal cognitive impairment

    Valproate's well-documented teratogenicity (neural tube defects, cognitive impairment) makes lamotrigine the preferred mood stabilizer for women who may become pregnant.

  6. A pregnant patient at 30 weeks develops severe insomnia. Which medication approach is most appropriate to discuss first?

    Answer: Sleep hygiene and CBT-I as first-line with short-term low-dose diphenhydramine if needed

    CBT for insomnia (CBT-I) is first-line; diphenhydramine is a relatively safer short-term option if pharmacotherapy is needed, while benzodiazepines and z-drugs carry higher fetal risk.

  7. Which statement about omega-3 fatty acid supplementation in perinatal mood disorders is most accurate?

    Answer: Evidence suggests EPA-rich omega-3s may have adjunctive benefit for perinatal depression with a favorable safety profile

    EPA-dominant omega-3 formulations show adjunctive antidepressant effect in perinatal populations and are generally safe, supporting their use as a complement to evidence-based treatment.